1469327-05-6

Basic information

• Product Name: tert-butyl 4-[4-(benzyloxy)-5-bromo-1H-indazole-1-yl]piperidine-1-carboxylate
• Synonyms: tert-butyl 4-[4-(benzyloxy)-5-bromo-1H-indazole-1-yl]piperidine-1-carboxylate
• CAS NO: 1469327-05-6
• Molecular Weight: 486.409
• Mol File: 1469327-05-6.mol

Chemical Properties

• CAS DataBase Reference: tert-butyl 4-[4-(benzyloxy)-5-bromo-1H-indazole-1-yl]piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-[4-(benzyloxy)-5-bromo-1H-indazole-1-yl]piperidine-1-carboxylate(1469327-05-6)
• EPA Substance Registry System: tert-butyl 4-[4-(benzyloxy)-5-bromo-1H-indazole-1-yl]piperidine-1-carboxylate(1469327-05-6)

Safety Data

• Hazardous Substances Data: 1469327-05-6(Hazardous Substances Data)

Upstream product

• 202857-88-3 2-Benzyloxy-1-bromo-4-fluoro-benzene 
• 850363-66-5 4-(benzyloxy)-5-bromo-1H-indazole 
• 141699-59-4 1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate 
• 1469327-04-5 2-(benzyloxy)-3-bromo-6-fluorobenzaldehyde 
• 100-39-0 benzyl bromide 
• 147460-41-1 2-bromo-5-fluorophenol 

Downstream Products

• 1469327-06-7 tert-butyl 4-[4-(benzyloxy)-5-methyl-1H-indazole-1-yl]piperidine-1-carboxylate 

Relevant articles and documents

PHARMACEUTICALS CONTAINING NOVEL 1-POSITION SUBSTITUTED INDAZOLE DERIVATIVE

PROBLEM TO BE SOLVED: To provide pharmaceuticals containing a compound having strong effect of modulating α7 nicotinic acetylcholine receptor (α7nAChR) and useful as treatment agent for diseases related to cholinergic in central nervous system (CNS) and/o

NOVEL 1-SUBSTITUTED INDAZOLE DERIVATIVE

A medicament for treating diseases associated with cholinergic properties in the central nervous system (CNS) and/or peripheral nervous system (PNS), diseases associated with smooth muscle contraction, endocrine disorders, neurodegenerative disorders and